AU2003210983A8 - Kinase inhibitors and methods of use thereof - Google Patents

Kinase inhibitors and methods of use thereof

Info

Publication number
AU2003210983A8
AU2003210983A8 AU2003210983A AU2003210983A AU2003210983A8 AU 2003210983 A8 AU2003210983 A8 AU 2003210983A8 AU 2003210983 A AU2003210983 A AU 2003210983A AU 2003210983 A AU2003210983 A AU 2003210983A AU 2003210983 A8 AU2003210983 A8 AU 2003210983A8
Authority
AU
Australia
Prior art keywords
methods
kinase inhibitors
kinase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003210983A
Other versions
AU2003210983A1 (en
Inventor
Ling Gu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU2003210983A8 publication Critical patent/AU2003210983A8/en
Publication of AU2003210983A1 publication Critical patent/AU2003210983A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
AU2003210983A 2002-02-11 2003-02-11 Kinase inhibitors and methods of use thereof Abandoned AU2003210983A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35588502P 2002-02-11 2002-02-11
US60/355,885 2002-02-11
PCT/US2003/004163 WO2003068157A2 (en) 2002-02-11 2003-02-11 Kinase inhibitors and methods of use thereof

Publications (2)

Publication Number Publication Date
AU2003210983A8 true AU2003210983A8 (en) 2003-09-04
AU2003210983A1 AU2003210983A1 (en) 2003-09-04

Family

ID=27734578

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003210983A Abandoned AU2003210983A1 (en) 2002-02-11 2003-02-11 Kinase inhibitors and methods of use thereof

Country Status (2)

Country Link
AU (1) AU2003210983A1 (en)
WO (1) WO2003068157A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058829A1 (en) 2003-12-11 2005-06-30 Board Of Regents, The University Of Texas System Compounds for treatment of cell proliferative diseases
US20100292229A1 (en) * 2006-06-30 2010-11-18 The Board Of Regents Of The University Of Texas System Tryphostin-analogs for the treatment of cell proliferative diseases
US8143412B2 (en) 2008-07-08 2012-03-27 Board Of Regents, The University Of Texas System Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)
WO2012127506A1 (en) 2011-03-22 2012-09-27 Advinus Therapeutics Limited Substituted fused tricyclic compounds, compositions and medicinal applications thereof
US8962831B2 (en) * 2011-05-17 2015-02-24 Principia Biopharma Inc. Tyrosine kinase inhibitors
WO2014039899A1 (en) 2012-09-10 2014-03-13 Principia Biopharma Inc. Pyrazolopyrimidine compounds as kinase inhibitors
IN2015DN02008A (en) 2012-09-21 2015-08-14 Advinus Therapeutics Ltd
BR112016018948B1 (en) 2014-02-21 2023-01-17 Principia Biopharma Inc USE OF COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT, SULFONIC ACID OR CARBOXYLIC ACID SALT OF COMPOUND, AMORPHOUS FORM OF PHARMACEUTICALLY ACCEPTABLE SALT OF COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF
US20170088520A1 (en) * 2014-06-02 2017-03-30 Pharmakea, Inc. Deubiquitinase inhibitors
MA41197B1 (en) 2014-12-18 2021-01-29 Principia Biopharma Inc Treatment of pemphigus
US20180305350A1 (en) 2015-06-24 2018-10-25 Principia Biopharma Inc. Tyrosine kinase inhibitors
MA45547A (en) 2016-06-29 2019-05-08 Principia Biopharma Inc MODIFIED RELEASE FORMULATIONS BASED ON 2- [3- [4-AMINO-3- (2-FLUORO-4-PHENOXY-PHENYL) PYRAZOLO [3,4-D] PYRIMIDINE-1-YL] PIPERIDINE-1-CARBONYL] -4-METHYL-4- [4- (OXETANE-3-YL) PIPERAZINE-1-YL] PENT-2-ENENITRILE
TW201922707A (en) 2017-11-10 2019-06-16 美國德州系統大學評議委員會 Caffeic acid derivatives and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5854285A (en) * 1997-04-03 1998-12-29 Natpro, Inc. Protein kinase inhibitor
CA2265396A1 (en) * 1999-03-12 2000-09-12 Chaim M. Roifman Methods and compositions for treating leukemia

Also Published As

Publication number Publication date
WO2003068157A2 (en) 2003-08-21
WO2003068157A3 (en) 2004-03-04
AU2003210983A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
AU2003303128A8 (en) Inhibitors and methods of use thereof
EG27049A (en) P38 inhibitors and methods of use thereof
PL378432A1 (en) P38 inhibitors and methods of use thereof
EP1601357A4 (en) Heterocyclic kinase inhibitors: methods of use and synthesis
EP1507756A4 (en) Ccr9 inhibitors and methods of use thereof
AU2003217870A8 (en) Pini-modulating compounds and methods of use thereof
PL375447A1 (en) Protein kinase inhibitors and uses thereof
IL173936A0 (en) Heterocyclic inhibitors of mek and methods of use thereof
EP1465615A4 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2003213673A8 (en) Pin1-modulating compounds and methods of use thereof
EP1534680A4 (en) Prenylation inhibitors and methods of their synthesis and use
HK1160859A1 (en) Inhibitors of tyrosine kinases
HK1072545A1 (en) Novel inhibitors of kinases
PL376789A1 (en) Aminoindazole derivatives and use thereof as kinase inhibitors
EP1448218A4 (en) Beta-secretase inhibitors and methods of use
EP1691812A4 (en) Gtpase inhibitors and methods of use
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2003210983A8 (en) Kinase inhibitors and methods of use thereof
PL374581A1 (en) Diaminothiazoles and use thereof as cdk4 inhibitors
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2003299815A1 (en) Matriptase inhibitors and methods of use
EP1682115A4 (en) Hif-1 inhibitors and methods of use thereof
EP1545287A4 (en) Vasoregulating compounds and methods of their use
AU2003238948A8 (en) Caspase-1 inhibitors and methods for their use
ZA200500492B (en) Novel inhibitors of kinases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase